134 related articles for article (PubMed ID: 20210798)
21. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.
Geneste O; Bidaud C; De Vita G; Hofstra RM; Tartare-Deckert S; Buys CH; Lenoir GM; Santoro M; Billaud M
Hum Mol Genet; 1999 Oct; 8(11):1989-99. PubMed ID: 10484767
[TBL] [Abstract][Full Text] [Related]
22. Grb2 binding to the different isoforms of Ret tyrosine kinase.
Alberti L; Borrello MG; Ghizzoni S; Torriti F; Rizzetti MG; Pierotti MA
Oncogene; 1998 Sep; 17(9):1079-87. PubMed ID: 9764818
[TBL] [Abstract][Full Text] [Related]
23. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
[TBL] [Abstract][Full Text] [Related]
24. Recruitment of Dok-R to the EGF receptor through its PTB domain is required for attenuation of Erk MAP kinase activation.
Jones N; Dumont DJ
Curr Biol; 1999 Sep; 9(18):1057-60. PubMed ID: 10508618
[TBL] [Abstract][Full Text] [Related]
25. Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival.
Lundgren TK; Scott RP; Smith M; Pawson T; Ernfors P
J Biol Chem; 2006 Oct; 281(40):29886-96. PubMed ID: 16847065
[TBL] [Abstract][Full Text] [Related]
26. Ret oncogene signal transduction via a IRS-2/PI 3-kinase/PKB and a SHC/Grb-2 dependent pathway: possible implication for transforming activity in NIH3T3 cells.
Hennige AM; Lammers R; Arlt D; Höppner W; Strack V; Niederfellner G; Seif FJ; Häring HU; Kellerer M
Mol Cell Endocrinol; 2000 Sep; 167(1-2):69-76. PubMed ID: 11000521
[TBL] [Abstract][Full Text] [Related]
27. Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF.
Ledda F; Bieraugel O; Fard SS; Vilar M; Paratcha G
J Neurosci; 2008 Jan; 28(1):39-49. PubMed ID: 18171921
[TBL] [Abstract][Full Text] [Related]
28. Intracellular RET signaling pathways activated by GDNF.
Kawai K; Takahashi M
Cell Tissue Res; 2020 Oct; 382(1):113-123. PubMed ID: 32816064
[TBL] [Abstract][Full Text] [Related]
29. Shc and Enigma are both required for mitogenic signaling by Ret/ptc2.
Durick K; Gill GN; Taylor SS
Mol Cell Biol; 1998 Apr; 18(4):2298-308. PubMed ID: 9528800
[TBL] [Abstract][Full Text] [Related]
30. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and biological responses induced by coupling of Gab1 to phosphatidylinositol 3-kinase in RET-expressing cells.
Maeda K; Murakami H; Yoshida R; Ichihara M; Abe A; Hirai M; Murohara T; Takahashi M
Biochem Biophys Res Commun; 2004 Oct; 323(1):345-54. PubMed ID: 15351743
[TBL] [Abstract][Full Text] [Related]
32. GDNF-mediated signaling via RET tyrosine 1062 is essential for maintenance of spermatogonial stem cells.
Jijiwa M; Kawai K; Fukihara J; Nakamura A; Hasegawa M; Suzuki C; Sato T; Enomoto A; Asai N; Murakumo Y; Takahashi M
Genes Cells; 2008 Apr; 13(4):365-74. PubMed ID: 18363967
[TBL] [Abstract][Full Text] [Related]
33. Downstream of kinase, p62(dok), is a mediator of Fc gamma IIB inhibition of Fc epsilon RI signaling.
Ott VL; Tamir I; Niki M; Pandolfi PP; Cambier JC
J Immunol; 2002 May; 168(9):4430-9. PubMed ID: 11970986
[TBL] [Abstract][Full Text] [Related]
34. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signalling molecules mediated by ret with the MEN 2B mutation.
Murakami H; Iwashita T; Asai N; Shimono Y; Iwata Y; Kawai K; Takahashi M
Biochem Biophys Res Commun; 1999 Aug; 262(1):68-75. PubMed ID: 10448070
[TBL] [Abstract][Full Text] [Related]
35. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
[TBL] [Abstract][Full Text] [Related]
36. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2.
Hishiki T; Nimura Y; Isogai E; Kondo K; Ichimiya S; Nakamura Y; Ozaki T; Sakiyama S; Hirose M; Seki N; Takahashi H; Ohnuma N; Tanabe M; Nakagawara A
Cancer Res; 1998 May; 58(10):2158-65. PubMed ID: 9605760
[TBL] [Abstract][Full Text] [Related]
37. Infrequent detectable somatic mutations of the RET and glial cell line-derived neurotrophic factor (GDNF) genes in human pituitary adenomas.
Yoshimoto K; Tanaka C; Moritani M; Shimizu E; Yamaoka T; Yamada S; Sano T; Itakura M
Endocr J; 1999 Feb; 46(1):199-207. PubMed ID: 10426588
[TBL] [Abstract][Full Text] [Related]
38. Protein-tyrosine phosphatase SHP2 contributes to GDNF neurotrophic activity through direct binding to phospho-Tyr687 in the RET receptor tyrosine kinase.
Perrinjaquet M; Vilar M; Ibáñez CF
J Biol Chem; 2010 Oct; 285(41):31867-75. PubMed ID: 20682772
[TBL] [Abstract][Full Text] [Related]
39. RET and neuroendocrine tumors.
Ichihara M; Murakumo Y; Takahashi M
Cancer Lett; 2004 Feb; 204(2):197-211. PubMed ID: 15013219
[TBL] [Abstract][Full Text] [Related]
40. Gas1 reduces Ret tyrosine 1062 phosphorylation and alters GDNF-mediated intracellular signaling.
López-Ramírez MA; Domínguez-Monzón G; Vergara P; Segovia J
Int J Dev Neurosci; 2008 Aug; 26(5):497-503. PubMed ID: 18394855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
